Clinical Trial Update: Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial update of Modified Hyper-CVAD regimen for acute lymphoblastic leukemia has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Adriamycin (doxorubicin)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Vincristine (vincristine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2020-12-03